Top Market Research Companies in Egypt (2026 Guide)
An independent guide to the leading market research companies operating in Egypt for 2026. This article profiles 5 firms across healthcare, pharmaceutical, and consumer research — comparing capabilities, methodologies, Egypt-specific expertise, and what to look for when shortlisting a research partner for the largest market in MENA.
Published April 2026 · By BioNixus Research Team · 14 min read
5
Firms profiled
$5.8B
Egypt pharma market
109M+
Population (largest MENA)
8
FAQs answered
Why Egypt Matters for Market Research in 2026
Egypt is the largest market in MENA by population (109M+) and has the strongest local pharmaceutical manufacturing base in the region, with approximately 90% of medicines consumed produced domestically. The pharmaceutical market is valued at $5.8 billion and growing at 9.2% year-over-year.
The Egyptian Drug Authority (EDA), established in 2020, is modernising pharmaceutical regulation. Universal Health Insurance (Hayah Karima) is expanding coverage, driving new demand for evidence-based decision-making. For multinational pharmaceutical companies, Egypt offers scale, a growing addressable market, and an export gateway to Africa.
For market research buyers, Egypt presents specific challenges: diverse stakeholder landscapes across government and private channels, Arabic-language requirements, EDA-specific regulatory context, and the need for culturally grounded fieldwork across Cairo, Alexandria, and Upper Egypt. Choosing the right research partner is critical.
For additional Egypt market context, see our pharmaceutical companies in Egypt guide and healthcare market research in Egypt hub. For the full strategic portfolio, visit the BioNixus strategic portfolio.
How to Evaluate a Market Research Partner for Egypt
When shortlisting market research companies for Egypt, consider these criteria beyond standard RFP evaluation. The Egypt market has specific requirements that differentiate effective research partners from generic providers.
Egypt pharma project experience
Track record of completed pharmaceutical and healthcare studies in Egypt
EDA regulatory awareness
Understanding of EDA registration, pricing, and pharmacovigilance requirements
Arabic-English bilingual execution
Ability to design and field studies in both languages with medical precision
Physician & KOL recruitment
Access to government and private hospital physicians, department heads, and KOLs
Quant + qual integration
Mixed-method capability combining surveys, interviews, and synthesis
Data integrity controls
Recruitment verification, response consistency, and audit trails
5 Leading Market Research Companies in Egypt (2026)
The following profiles cover the leading market research firms operating in Egypt, ordered by Egypt-specific healthcare and pharma research capability. Each profile assesses scope, methodology, and practical relevance for pharmaceutical and consumer research buyers.
BioNixus
BioNixus is headquartered in the USA with regional offices in the UK and Egypt, making it the only firm with this structure offering dual-practice coverage across healthcare/pharma and consumer sectors. With 127+ completed projects, 48 global clients, and a 15-year track record, BioNixus combines deep local fieldwork capability with international research standards. The firm specialises in pharmaceutical market research, KOL mapping, competitive intelligence, market access strategy, HEOR, and brand health tracking — executing bilingual Arabic-English studies across government and private channels.
Key strengths
- Dual-practice: healthcare/pharma + consumer research
- 127+ completed Egypt and MENA projects
- EDA-aware regulatory and market access research
- Arabic-English bilingual field execution
- Physician surveys, KOL mapping, payer research
- HEOR, pharmacoeconomics, and HTA support
Kantar Egypt
Kantar maintains an Egypt office within its global network. The firm provides brand tracking, consumer insights, and media measurement at scale. In the healthcare segment, Kantar Health (now part of Kantar) has supported pharma teams with physician studies, patient journey mapping, and syndicated data. Their strength lies in large-scale quantitative programmes and global benchmarking capabilities, though pharma-specific depth in MENA can depend on project staffing.
Key strengths
- Global brand health and consumer tracking
- Large quantitative survey infrastructure
- Syndicated data and media analytics
- Healthcare division for pharma studies
Ipsos Egypt
Ipsos has had a presence in Egypt for over two decades, providing market research across consumer, public affairs, and healthcare sectors. The healthcare division supports pharmaceutical clients with physician attitude and usage studies, patient research, and advertising testing. Ipsos brings strong methodological rigour and large sample capabilities. Egypt-specific pharma depth relies on the availability of specialist healthcare researchers within the local office.
Key strengths
- Two decades of Egypt presence
- Healthcare division with pharma methodology
- Strong quantitative and qualitative methods
- Public affairs and social research
Nielsen (NielsenIQ)
NielsenIQ provides retail measurement, consumer panels, and shopper analytics in Egypt. Their strength is in FMCG and consumer goods tracking through point-of-sale data and household panels. For pharmaceutical companies focused on OTC and consumer health, Nielsen retail data can be valuable. However, their Egypt coverage is primarily consumer/retail, with limited prescription pharma or healthcare stakeholder research.
Key strengths
- Retail measurement and shopper panels
- FMCG and OTC tracking
- Point-of-sale data analytics
- Consumer trend and market sizing
Euromonitor International
Euromonitor provides syndicated market reports and data across industries including consumer health, OTC pharmaceuticals, and consumer goods in Egypt. Their Passport database offers market sizing, competitive landscapes, and trend analysis. For pharmaceutical companies, Euromonitor is valuable for market entry assessment and category sizing but does not offer custom primary research or physician-level fieldwork.
Key strengths
- Syndicated market data and reports
- Egypt consumer health and OTC coverage
- Market sizing and competitive landscapes
- Industry trend analysis
Healthcare vs Consumer: Choosing the Right Research Model
Egypt market research spans two broad domains: healthcare/pharma and consumer/FMCG. Most global networks (Kantar, Ipsos, Nielsen) serve both but through separate divisions with varying depth in pharma-specific work.
For pharmaceutical market research, the key differentiator is access to healthcare professionals. Physician surveys, KOL mapping, payer interviews, and formulary research require specialist recruitment networks and medical terminology expertise. Consumer panels cannot substitute for targeted HCP research.
BioNixus is uniquely positioned as the only firm in this guide offering genuine dual-practice coverage — both healthcare/pharma and consumer research from a US-headquartered operation with regional offices in the UK and Egypt. This means clients working across both domains (e.g., OTC + Rx, or consumer health + specialist pharma) can consolidate with one partner.
For syndicated market data, Euromonitor and NielsenIQ provide valuable sizing and trend information. However, syndicated data should complement, not replace, custom primary research that addresses your specific business questions.
Methodology & Selection Criteria
This guide profiles market research companies with demonstrated presence in Egypt as of 2026. Selection criteria include: (1) active Egypt operations or fieldwork capability, (2) relevance to healthcare, pharmaceutical, or consumer research buyers, (3) established track record with identifiable client engagements. Firms are ordered by Egypt-specific healthcare and pharma capability.
This guide is maintained by the BioNixus research team. BioNixus is profiled in this guide and is transparent about its inclusion. For corrections or updates, contact our team.
Frequently Asked Questions
What are the top market research companies in Egypt?
Leading market research firms in Egypt include BioNixus, Kantar Egypt, Ipsos Egypt, NielsenIQ, and Euromonitor International. BioNixus is the only Egypt-based firm offering dual-practice coverage across both healthcare/pharma and consumer research with 127+ completed projects.
How much does market research cost in Egypt?
Custom market research engagements in Egypt typically range from $15,000 to $50,000 per project depending on scope, methodology, geography, and therapeutic or sector complexity. Syndicated reports range from $2,000–$10,000. Multi-country MENA programmes start higher.
Which firm does pharma market research in Egypt?
BioNixus specialises in pharmaceutical market research in Egypt and the wider MENA region, covering KOL mapping, market access, HTA submissions, pharmacoeconomics, launch readiness, and competitive intelligence for global pharma clients. Ipsos and Kantar also have healthcare divisions with varying Egypt-specific depth.
Should I use a global network or local specialist for Egypt research?
It depends on your needs. Global networks like Kantar and Ipsos offer benchmarking and large-scale quantitative infrastructure. Local specialists like BioNixus offer deeper Egypt market knowledge, EDA regulatory awareness, and bilingual Arabic-English execution. Many clients combine both — using a specialist for primary pharma research and global firms for syndicated tracking.
What research methods work best in Egypt?
The most reliable approach in Egypt is usually a mixed-method design. BioNixus uses quantitative surveys (CATI, online), in-depth qualitative interviews, and targeted KOL mapping with strict recruitment validation. Method selection is guided by the business question — launch readiness may require physician quant plus depth interviews, while market access may prioritise payer qualitative insight.
How does the EDA affect market research planning in Egypt?
The Egyptian Drug Authority (EDA) oversees drug registration, pricing, and pharmacovigilance. Registration takes 12–24 months. Market research must account for EDA requirements when generating evidence for regulatory submissions, formulary decisions, and market access strategy. BioNixus structures research around EDA realities.
Can I run bilingual Arabic-English studies in Egypt?
Yes. BioNixus supports Arabic and English as standard for all Egypt studies. Instruments are translated with controlled medical terminology review so questions retain clinical precision and strategic intent. Bilingual capability is essential for reaching both Arabic-speaking physicians and international stakeholders in Egypt.
How do I evaluate a market research firm for Egypt healthcare work?
Key criteria include: (1) Egypt-specific pharma experience, (2) EDA regulatory awareness, (3) Arabic-English bilingual execution, (4) physician and KOL recruitment quality, (5) data integrity controls, (6) therapy area depth, and (7) ability to connect findings to commercial decisions. Request case studies and respondent quality documentation.
Related Resources
BioNixus Strategic Portfolio
Full portfolio of market research and consulting capabilities.
Pharmaceutical Companies in Egypt
20+ pharma companies, $5.8B market data, EDA guide.
Healthcare Market Research in Egypt
Country hub with FAQs, key stats, and therapy focus.
Market Research Egypt
Pharma and healthcare intelligence landing page.
Blog Version of This Guide
Read the blog post version with related articles.
Request a Proposal
Get in touch for a custom Egypt research engagement.
Scope Healthcare Market Research for Egypt
BioNixus delivers custom pharmaceutical and consumer market research across Egypt and MENA — physician surveys, KOL mapping, competitive intelligence, market access strategy, and HEOR.